Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX $438.92)
- $438.92 P/E (TTM): 31.8X Cap: $114.05B
- View VRTX Profile
- View Questions on VRTX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $541.34)
- $541.34 P/E (TTM): 74.22X Cap: $193.82B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $438.92)
- $438.92 P/E (TTM): 31.8X Cap: $114.05B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $216.75)
- $216.75 P/E (TTM): 168.51X Cap: $392.16B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $219.57)
- $219.57 P/E (TTM): 20.62X Cap: $526.55B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,032.97)
- $1,032.97 P/E (TTM): 52.7X Cap: $1.01T
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $110.97)
- $110.97 P/E (TTM): 14.31X Cap: $275.52B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $170.56)
- $170.56 P/E (TTM): 21.3X Cap: $8.62B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $712.12)
- $712.12 P/E (TTM): 56.62X Cap: $56.73B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $71.82)
- $71.82 P/E (TTM): 16.4X Cap: $8.57B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $105.24)
- $105.24 P/E (TTM): 17.68X Cap: $20.80B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $22.96)
- $22.96 P/E (TTM): 12.99X Cap: $2.84B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $24.93)
- $24.93 P/E (TTM): 320.42X Cap: $204.58B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Vertex Pharmaceuticals Incorporated (VRTX $438.92)
- $438.92 P/E (TTM): 31.8X Cap: $114.05B
- View VRTX Profile
- View Questions on VRTX
CRISPR Therapeutics AG (CRSP $54.21)
- $54.21 Cap: $5.42B
- View CRSP Profile
- View Questions on CRSP

Q: What is your opinion regarding the future of CRSP? Buy, sell, hold?

Read Answer Asked by Judith on May 21, 2025

Vertex Pharmaceuticals Incorporated (VRTX $438.92)
- $438.92 P/E (TTM): 31.8X Cap: $114.05B
- View VRTX Profile
- View Questions on VRTX

Q: May I please get your thoughts on this company? I like their new non-opioid pain killer that was just approved by the FDA for a strong growth prospect. I am curious what you think about the existing business and the fundamentals/financials of the company. Thanks.

Read Answer Asked by Marco on February 14, 2025